BARBUI, Corrado
 Distribuzione geografica
Continente #
NA - Nord America 15.332
EU - Europa 14.864
AS - Asia 6.502
SA - Sud America 410
AF - Africa 113
OC - Oceania 72
Continente sconosciuto - Info sul continente non disponibili 15
Totale 37.308
Nazione #
US - Stati Uniti d'America 15.070
GB - Regno Unito 5.874
CN - Cina 3.427
SG - Singapore 2.334
IT - Italia 1.630
RU - Federazione Russa 1.402
FR - Francia 1.357
DE - Germania 1.152
IE - Irlanda 1.077
SE - Svezia 868
FI - Finlandia 819
BR - Brasile 339
UA - Ucraina 336
CA - Canada 237
VN - Vietnam 212
ID - Indonesia 112
TR - Turchia 100
NL - Olanda 83
AU - Australia 62
HK - Hong Kong 61
BE - Belgio 60
TG - Togo 55
IN - India 49
JP - Giappone 38
AT - Austria 37
ES - Italia 32
MY - Malesia 23
PE - Perù 23
IL - Israele 22
KR - Corea 22
ZA - Sudafrica 20
RO - Romania 19
EU - Europa 14
HU - Ungheria 14
MX - Messico 13
CL - Cile 11
PL - Polonia 11
UZ - Uzbekistan 11
CZ - Repubblica Ceca 10
GR - Grecia 10
PK - Pakistan 10
CH - Svizzera 9
IR - Iran 9
MA - Marocco 9
VE - Venezuela 9
AR - Argentina 8
NZ - Nuova Zelanda 8
PH - Filippine 8
SK - Slovacchia (Repubblica Slovacca) 8
BG - Bulgaria 7
DK - Danimarca 7
EG - Egitto 7
IQ - Iraq 7
AZ - Azerbaigian 6
BD - Bangladesh 6
CO - Colombia 6
PT - Portogallo 6
BY - Bielorussia 5
EC - Ecuador 5
PA - Panama 5
TH - Thailandia 5
TW - Taiwan 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
CD - Congo 4
EE - Estonia 4
JO - Giordania 4
KE - Kenya 4
LA - Repubblica Popolare Democratica del Laos 4
NO - Norvegia 4
RS - Serbia 4
SI - Slovenia 4
AM - Armenia 3
HR - Croazia 3
JM - Giamaica 3
KG - Kirghizistan 3
MD - Moldavia 3
SC - Seychelles 3
BO - Bolivia 2
BW - Botswana 2
CM - Camerun 2
FJ - Figi 2
GE - Georgia 2
GT - Guatemala 2
IS - Islanda 2
KH - Cambogia 2
LK - Sri Lanka 2
LT - Lituania 2
LU - Lussemburgo 2
LV - Lettonia 2
NG - Nigeria 2
NP - Nepal 2
OM - Oman 2
PS - Palestinian Territory 2
PY - Paraguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
CG - Congo 1
CI - Costa d'Avorio 1
Totale 37.299
Città #
Southend 5.506
Jacksonville 2.742
Chandler 2.239
Singapore 1.823
Woodbridge 1.651
Houston 1.159
Ann Arbor 1.065
Dublin 1.047
Ashburn 671
Beijing 544
Wilmington 527
Lawrence 504
Princeton 501
Verona 470
Nanjing 304
Jinan 294
New York 243
Shenyang 237
Sindelfingen 212
Helsinki 184
Hebei 176
Milan 172
Munich 159
Montréal 137
Mcallen 131
Dong Ket 130
Tianjin 121
Boardman 115
Nanchang 112
Haikou 108
Changsha 105
Jakarta 103
Ningbo 95
Dearborn 90
Washington 80
Zhengzhou 80
Hangzhou 77
Jiaxing 74
Guangzhou 73
Norwalk 72
Redwood City 68
Seattle 68
Santa Clara 66
Toronto 66
Rome 63
Moscow 62
Taizhou 62
Los Angeles 60
Taiyuan 58
Lomé 55
Brussels 51
Dallas 50
Lanzhou 50
Hong Kong 49
Fairfield 42
Kent 42
San Francisco 41
Redmond 40
Lappeenranta 39
Amsterdam 36
Düsseldorf 33
Nuremberg 32
Chicago 31
Fuzhou 31
Berlin 29
Tokyo 28
London 26
São Paulo 25
Vienna 25
Bologna 24
Kuala Lumpur 21
Lancaster 21
Florence 19
Falls Church 18
Brisbane 17
Dongguan 16
Falkenstein 16
Melbourne 15
Shanghai 15
Fort Worth 13
Frankfurt am Main 13
Padova 13
Seoul 13
Stockholm 13
Turin 13
Auburn Hills 12
Buffalo 12
Cambridge 12
Madrid 12
Paris 12
Romola 12
San Diego 12
Roverbella 11
Saint Petersburg 11
Wuhan 11
Belo Horizonte 10
Porto Alegre 10
Rio de Janeiro 10
Baltimore 9
Canberra 9
Totale 25.886
Nome #
Forty years without mental hospitals in Italy 577
WHO Mental Health Gap Action Programme (mhGAP) Intervention Guide: a systematic review of evidence from low and middle-income countries 469
Efficacia del litio nella depressione resistente con rischio suicidario. Studio indipendente, pragmatico, multicentrico, di superiorità 420
Beyond pain: can antidepressants improve depressive symptoms and quality of life in patients with neuropathic pain? A systematic review and meta-analysis 326
Efficacia del litio nella depressione resistente con rischio suicidario. Studio indipendente, pragmatico, multicentrico, di superiorità 321
Il trattamento farmacologico degli attacchi di panico in medicina generale 178
Psychological treatments versus treatment as usual for obsessive compulsive disorder 172
[(123)I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism. 168
Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications 156
Cerebral atrophy and white matter disruption in chronic schizophrenia 146
Development of a registry for monitoring psychotropic drug prescriptions: Aims, methods and implications for ordinary practice and research 136
What is the WHO essential medicines list? 136
Psychosocial interventions for post-traumatic stress disorder in refugees and asylum seekers resettled in high-income countries: Systematic review and meta-analysis 133
Come reagiscono al trauma i bambini sfollati? Un’analisi esplorativa degli studi condotti in contesti di guerra. [Displaced versus non-displaced children in war contexts: An explorative analysis of psychological reactions to war experiences] 130
[Randomized trials, systematic reviews, meta-analyses: basic criteria in the world of scientific evidence]. 128
Efficacia della “Terapia per l’adesione al trattamento” sulla qualità della vita di persone affette da schizofrenia e dei loro familiari (progetto QUATRO). Razionale dello studio e metodologia 127
Ricostruzione tridimensionale della volumetria cerebrale nella schizofrenia 126
Assessing risk of bias in randomized controlled trials 125
Clinical interventions for treatment non-adherence in psychosis: meta-analysis 125
Predicting costs of mental health care: a critical literature review 124
Trazodone nell'anziano con problemi di insonnia: quale il razionale? 123
Common mental disorders in asylum seekers and refugees: umbrella review of prevalence and intervention studies 122
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial 121
Amitriptyline versus other tricyclic drugs and selectivev serotonine reuptake inhibitors (SSRIs) for depression [Protocoll] 119
Assessment of cerebral blood volume in schizophrenia: a magnetic resonance imaging study 118
Commentary: Haloperidol, risperidone and olanzapine are similarly effective for first-episode non-affective psychosis but have differing side effects 115
Making the use of psychotropic drugs more rational through the development of GRADE recommendations in specialist mental healthcare 115
Guideline implementation strategies for specialist mental healthcare. 111
Are all antidepressants really the same? The case of fluoxetine: a systematic review 110
Identification and management of depression in primary care settings. A meta-review of evidence 110
What is a systematic review? 110
A simple approach to manage dosages in drug-epidemiology research 110
Adverse effects of antipsychotic drugs: survey of doctors' versus patients' perspective. 109
A New Approach to Psychiatric Drug Approval in Europe 107
Associazione tra TCA e SSRI nella depressione resistente 106
Imputing missing standard deviations in meta-analyses can provide accurate results 106
Antidepressant and antipsychotic drug prescribing in general population in Lombardy (in Italian) 106
Cortical white-matter microstructure in schizophrenia. Diffusion imaging study. 106
Response rates in patients with schizophrenia and positive symptoms receiving cognitive behavioural therapy: a systematic review and single-group meta-analysis 106
Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy 105
Avoidable mortality of psychiatric patients in an area with a community-based system of mental health care. 105
Efficacy of pharmacotherapy against core traits of borderline personality disorder: Meta-analysis of randomized controlled trials 104
Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval 103
What is a forest plot? 102
La identificación y tratamiento de la enfermedad mental en atención primaria: el caso de la depresión 102
Antidepressants and benzodiazepines for panic disorder in adults 102
Violence in psychiatric units. A 7-year Italian study of persistently assaultive patients 101
Determinants of first- and second-generation antipsychotic drug use in clinically unstable patients with schizophrenia treated in four European countries 100
Off-label and non-classical prescriptions of antipsychotic agents in ordinary inpatient practice 100
Allocation concealment and blinding in clinical trials 100
Agomelatine and the brave old world of narrative-based medicine 100
Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature 100
Persistence with polypharmacy and excessive dosing in patients with schizophrenia treated in four European countries 100
Trasformare la pratica clinica in ricerca. Un invito a partecipare allo studio CHAT 98
Citalopram versus other anti-depressive agents for depression 98
Medicina basata sulle prove di efficacia e pratica clinica quotidiana: il caso degli antidepressivi 97
Persistence with pharmacological treatment in the specialist mental healthcare of patients with severe mental disorders 97
Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: results and lessons of an underpowered randomised clinical trial 97
Efficacy and acceptability of psychosocial interventions in asylum seekers and refugees: systematic review and meta-analysis 97
Forty-five years of schizophrenia trials in Italy: a survey 97
What is a risk ratio? 96
Antidepressant drug prescription and risk of abnormal bleeding. A case-control study 96
Antidepressant agents: from tricyclics to serotonin uptake inhibitors. 95
Randomized trials published in Chinese or Western journals: comparative empirical analysis 95
Drug dose as mediator of treatment effect in antidepressant drug trials: the case of fluoxetine 95
Disturbo d'ansia generalizzato: enigma clinico o questione di marketing? 94
Generating psychotropic drug exposure data from computer-based medical records 94
Effect of antipsychotic drugs on cerebrovascular morbidity and mortality: a systematic review 94
Understanding antipsychotic non-classical prescriptions: a quantitative and qualitative approach 94
Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence 94
Academic psychiatry and the pharmaceutical industry: useful partnership or dangerous interaction? 93
Beneficial and adverse effects of antidepressants on suicide mortality in individuals with major depression 93
Sertraline versus other antidepressive agents for depression 93
The use of psychotropic drugs in an Italian psychiatric hospital: a two-year-long follow-up study. 93
What is the European Medicines Agency? 93
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial 93
Setective serotonin reuptake inbibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence [Review] 92
Seven criteria for improving effectiveness trials in psychiatry 92
Health status, resource consumption, and costs of dysthymic patients in Italian primary care 92
Authors' reply to Magrini and colleagues 92
First-generation antipsychotics and QTc: any role for mediating variables? 92
Access to and use of psychiatric services by migrants resettled in Northern Italy 92
Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia 92
Antidepressive Monotherapie 91
Adding aripiprazole improves major depressive disorder following incomplete response to antidepressants alone 91
Mapping the evidence on pharmacological interventions for non-affective psychosis in humanitarian non-specialised settings: a UNHCR clinical guidance 90
Decision models in the evaluation of psychotropic drugs. Useful tool or useless toy? 89
Efficacy of selective serotonin reuptake inhibitors and adverse events: meta-regression and mediation analysis of placebo-controlled trials 89
Psychological and psychosomatic symptoms of second victims of adverse events: a systematic review and meta-analysis 89
Maintenance treatment with long-acting injectable antipsychotics for people with nonaffective psychoses: a network meta-analysis 89
The changing pattern of inpatient antipsychotic drug use in Italy 88
Antipsychotic drugs and cerebrovascular events in elderly patients with dementia: a systematic review 88
Does placebo help establish equivalence in trials of new antidepressants? 87
Health status, resource consumption, and costs of dysthymia. A multi-center two-year longitudinal study 87
Management of acute stress, PTSD, and bereavement 87
Conventional vs. atypical antipsychotic medications [Letter] 86
Citalopram versus other anti-depressive agents for depression 86
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis 86
Schizophrenia trials conducted in African countries: a drop of evidence in the ocean of morbidity? 86
Azapirones versus placebo for panic disorder in adults 86
Totale 12.102
Categoria #
all - tutte 140.524
article - articoli 134.812
book - libri 774
conference - conferenze 983
curatela - curatele 0
other - altro 1.570
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.385
Totale 281.048


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.641 0 0 0 0 0 0 0 365 154 442 222 458
2020/20213.988 376 670 140 368 476 463 68 313 288 146 410 270
2021/20223.270 184 725 57 154 249 64 39 221 134 106 340 997
2022/20237.161 602 496 801 1.178 690 1.566 102 479 849 88 189 121
2023/20244.040 209 367 319 448 529 576 205 260 61 180 502 384
2024/20255.392 704 714 557 1.746 589 416 636 30 0 0 0 0
Totale 37.770